IN8bio, Inc (INAB) Prices $12.4M Offering at $0.395/unit

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. VZ
9. SPY
10. LMT

Go back to IN8bio, Inc (INAB) Prices $12.4M Offering at $0.395/unit

IN8bio Announces Pricing of $12.4 Million Private Placement

October 1, 2024 8:00 AM EDT

Cash position now expected to fund current operating plan into 2026 Financing provides cash runway to advance the ongoing expansion cohorts in the Phase 1 trial of INB-100 for patients with Acute Myeloid Leukemia (AML)

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced that it has entered into a... More